News
Doctors discuss the prevalence, risks and treatments of metastatic melanoma, as Teddi Mellencamp reveals the latest updates ...
Study findings show that the standardized 6-month surveillance protocols for all patients with low-risk uveal melanoma may be ...
A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence ...
Kevin Ashton, a sorority chef and content creator, had been diagnosed with stage 4 metastatic melanoma, but is now ...
My sister-in-law is 82 years old and was recently diagnosed with melanoma. She has an appointment for treatment in a couple of weeks. I thought this was a serious and deadly disease. Can a patient ...
5d
Live Science on MSNSimple blood test could help reveal whether melanoma will come backA simple blood test could reveal who is at high risk of skin cancer recurrence after tumor-removal surgery. The test can ...
16h
Oxford Mail on MSNNew cancer treatment available on NHS described as 'early Christmas present'A cancer treatment described as 'the best early Christmas present I could've asked for', has been given FDA and NICE approval ...
A novel approach to tumor-infiltrating lymphocyte therapy yielded higher response rates among patients with metastatic ...
HealthDay News — For patients with unresectable metastatic uveal melanoma (mUM), the drug/device combination melphalan/hepatic delivery system (HDS) is efficacious and has a favorable risk-benefit ...
Erasca continues developing novel RAS-pathway cancer drugs, backed by funding through 2027 and promising early results. Find ...
Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results